Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Hydrogel Endovascular Aneurysm Treatment Trial

ClinicalTrials.gov ID: NCT01407952

Public ClinicalTrials.gov record NCT01407952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 5:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

New Generation Hydrogel Endovascular Aneurysm Treatment Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is being done to test the effectiveness of a new generation FDA approved device for treating aneurysms compared to the current standard device for endovascular aneurysm treatment which is bare platinum coils. Endovascular procedures are a form of minimally invasive surgery, which is performed on blood vessels. The technique involves the introduction of a catheter which is a long, thin, flexible, hollow plastic tube through the skin into a large blood vessel. Typically the chosen blood vessel is the femoral artery found near the groin. The catheter is then maneuvered through the body to the location of the aneurysm in the brain using image guidance. Coils are delivered into the aneurysm through the catheters. Once the coils are delivered in the aneurysm, they are detached from the catheter. This is repeated until enough coils fill the aneurysm, blocking the blood flow to the aneurysm. The body responds by forming blood clots around the coil(s), which helps block the flow of blood into the aneurysm and keeps the vessel from rupturing or leaking. This study will compare the study device to the standard bare platinum coil to see which is better at preventing future rupturing or leaking. The study device is called the HydroCoil Embolization System and this study is a post-market clinical trial. About 600 subjects from multiple institutions will take part in this study.

Study identification

NCT ID
NCT01407952
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Northwestern University
Other
Enrollment
600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2012
Primary completion
Feb 28, 2018
Completion
Feb 28, 2018
Last update posted
Jun 26, 2019

2012 – 2018

United States locations

U.S. sites
38
U.S. states
25
U.S. cities
34
Facility City State ZIP Site status
St. Joseph's Hospital Phoenix Arizona 85013
Mercy General Hospital Sacramento California 95819
Kaiser Permanente Sacramento Sacramento California 95825
Christiana Hospital Newark Delaware 19718
Lyerly Neurosurgery Jacksonville Florida 32207
Mayo Clinic Jacksonville Florida 32224
Baptist Cardiac and Vascular Institute Miami Florida 33176
Queens Medical Center Honolulu Hawaii 96813
Northwestern University Chicago Illinois 60611
Advocate Health Oak Lawn Illinois 60453
University of Louisville Louisville Kentucky 40202
Norton Healthcare Louisville Kentucky 40207
University of Maryland Baltimore Maryland 21201
Massachusetts General Hospital Boston Massachusetts 02114
University of Michigan Ann Arbor Michigan 48109
Consulting Radiologists, LTD Minneapolis Minnesota 55407
University of Minnesota Minneapolis Minnesota 55455
Mayo Clinic Rochester Minnesota 55905
Washington University St Louis Missouri 63110
Capital Health Regional Medical Center Trenton New Jersey 08638
Albany Medical College Albany New York 12208
Columbia University New York New York 10032
SUNY Stony Brook Stony Brook New York 11794
SUNY Upstate Medical University Syracuse New York 13210
East Carolina University Greenville North Carolina 27834
Cleveland Clinic Cleveland Ohio 44122
Ohio State University Columbus Ohio 43210
Oklahoma University Health Sciences Center Oklahoma City Oklahoma 73104
Kaiser Permanente NW Clackamas Oregon 07015
Oregon Health and Science University Portland Oregon 97239
UPMC Hamot Erie Pennsylvania 16507
Thomas Jefferson University Philadelphia Pennsylvania 19107
Rhode Island Hospital Providence Rhode Island 02903
Medical University of South Carolina Charleston South Carolina 29425
Methodist Hospital Research Institute Houston Texas 77030
University of Virginia Charlottesville Virginia 22908
MultiCare Health System Tacoma Washington 98405
West Virginia University Morgantown West Virginia 26508

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01407952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2019 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01407952 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →